UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 311

Sortiert nach

Distribution and characteristics of malignant tumours by lung lobe

BMC pulmonary medicine, 2024-03, Vol.24 (1), p.106-106, Article 106

2024

Volltextzugriff (PDF)

NIPU: a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma

Journal of translational medicine, 2021-05, Vol.19 (1), p.1-232, Article 232

2021

Volltextzugriff (PDF)

Sex-specific trends in lung cancer incidence and survival: a population study of 40 118 cases

Thorax, 2011-04, Vol.66 (4), p.301-307

2011

Volltextzugriff (PDF)

Osteopontin is a prognostic biomarker in non-small cell lung cancer

BMC cancer, 2013-11, Vol.13 (1), p.540-540, Article 540

2013

Volltextzugriff (PDF)

Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data

Genome Biology, 2015-01, Vol.16 (1), p.7-7, Article 7

2015

Volltextzugriff (PDF)

Epigenetic modifications in KDM lysine demethylases associate with survival of early-stage NSCLC

Clinical epigenetics, 2018-04, Vol.10 (1), p.41-41, Article 41

2018

Volltextzugriff (PDF)

NUT expression in primary lung tumours

Diagnostic pathology, 2015-09, Vol.10 (1), p.156-156, Article 156

2015

Volltextzugriff (PDF)

Detection of disseminated tumor cells in lymph nodes from patients with early stage non-small cell lung cancer

Diagnostic pathology, 2016-06, Vol.11 (1), p.50-50, Article 50

2016

Volltextzugriff (PDF)

Immune Cell Composition in Human Non-small Cell Lung Cancer

Frontiers in immunology, 2019-02, Vol.9, p.3101

2019

Volltextzugriff (PDF)

Multi‐omics analysis reveals epigenetically regulated processes and patient classification in lung adenocarcinoma

International journal of cancer, 2024-07, Vol.155 (2), p.282-297

2024

Volltextzugriff (PDF)

Groundbreaking basic research

Tidsskrift for den Norske Lægeforening, 2018-12, Vol.138 (20)

Helland, Åslaug

2018

Volltextzugriff (PDF)

Improvements in survival for patients with stage IV adenocarcinoma in the lung, diagnosed between 2010 - 2020 - A population-based registry study from Norway

Frontiers in oncology, 2022-11, Vol.12, p.1017902-1017902

2022

Volltextzugriff (PDF)

Atezolizumab Treatment Beyond Progression in Advanced NSCLC: Results From the Randomized, Phase III OAK Study

Journal of thoracic oncology, 2018-12, Vol.13 (12), p.1906-1918

2018

Volltextzugriff (PDF)

The immune microenvironment in non‐small cell lung cancer is predictive of prognosis after surgery

Molecular oncology, 2019-05, Vol.13 (5), p.1166-1179

2019

Volltextzugriff (PDF)

Initial investigation of using Norwegian health data for the purpose of external comparator arms - an example for non-small cell lung cancer

Acta oncologica, 2023-12, Vol.62 (12), p.1642-1648

2023

Volltextzugriff (PDF)

Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage–SCLC: Results From the Phase 3 MERU Study

Journal of thoracic oncology, 2021-09, Vol.16 (9), p.1570-1581

2021

Volltextzugriff (PDF)

Inference of Tumor Evolution during Chemotherapy by Computational Modeling and In Situ Analysis of Genetic and Phenotypic Cellular Diversity

Cell reports (Cambridge), 2014-02, Vol.6 (3), p.514-527

2014

Volltextzugriff (PDF)

The Immune Landscape of Human Primary Lung Tumors Is Th2 Skewed

Frontiers in immunology, 2021-11, Vol.12, p.764596-764596

2021

Volltextzugriff (PDF)

Intratumor heterogeneity defines treatment‐resistant HER2+ breast tumors

Molecular oncology, 2018-11, Vol.12 (11), p.1838-1855

2018

Volltextzugriff (PDF)

COVID-19 in Cancer Patients, Risk Factors for Disease and Adverse Outcome, a Population-Based Study From Norway

Frontiers in oncology, 2021-03, Vol.11, p.652535-652535

2021

Volltextzugriff (PDF)

Handling missing MRI sequences in deep learning segmentation of brain metastases: a multicenter study

NPJ digital medicine, 2021-02, Vol.4 (1), p.33-33, Article 33

2021

Volltextzugriff (PDF)

Acta Oncologica Nordic Precision Cancer Medicine Symposium 2023 – merging clinical research and standard healthcare

Acta oncologica, 2024-06, Vol.63 (1), p.487-490

2024

Volltextzugriff (PDF)

Factors associated with failure to start consolidation durvalumab after definitive chemoradiation for locally advanced NSCLC

Frontiers in oncology, 2023, Vol.13, p.1217424-1217424

2023

Volltextzugriff (PDF)

Rapid reduction in the incidence of cancer of unknown primary. A population-based study

Acta oncologica, 2014-01, Vol.53 (1), p.134-137

2014

Volltextzugriff (PDF)

1 – 25 von 311

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(298)
Mit Volltextzugriff
(302)

Publikationsform

Sprache

Englisch
(232)
Norwegisch
(130)
Japanisch
(29)
Bokmål, Norwegian; Norwegian Bokmål
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Distribution and characteristics of malignant tumours by lung lobe

NIPU: a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma

Sex-specific trends in lung cancer incidence and survival: a population study of 40 118 cases

Osteopontin is a prognostic biomarker in non-small cell lung cancer

Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data

Epigenetic modifications in KDM lysine demethylases associate with survival of early-stage NSCLC

NUT expression in primary lung tumours

Detection of disseminated tumor cells in lymph nodes from patients with early stage non-small cell lung cancer

Immune Cell Composition in Human Non-small Cell Lung Cancer

Multi‐omics analysis reveals epigenetically regulated processes and patient classification in lung adenocarcinoma

Groundbreaking basic research

Improvements in survival for patients with stage IV adenocarcinoma in the lung, diagnosed between 2010 - 2020 - A population-based registry study from Norway

Atezolizumab Treatment Beyond Progression in Advanced NSCLC: Results From the Randomized, Phase III OAK Study

The immune microenvironment in non‐small cell lung cancer is predictive of prognosis after surgery

Initial investigation of using Norwegian health data for the purpose of external comparator arms - an example for non-small cell lung cancer

Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage–SCLC: Results From the Phase 3 MERU Study

Inference of Tumor Evolution during Chemotherapy by Computational Modeling and In Situ Analysis of Genetic and Phenotypic Cellular Diversity

The Immune Landscape of Human Primary Lung Tumors Is Th2 Skewed

Intratumor heterogeneity defines treatment‐resistant HER2+ breast tumors

Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking

COVID-19 in Cancer Patients, Risk Factors for Disease and Adverse Outcome, a Population-Based Study From Norway

Handling missing MRI sequences in deep learning segmentation of brain metastases: a multicenter study

Acta Oncologica Nordic Precision Cancer Medicine Symposium 2023 – merging clinical research and standard healthcare

Factors associated with failure to start consolidation durvalumab after definitive chemoradiation for locally advanced NSCLC

Rapid reduction in the incidence of cancer of unknown primary. A population-based study

Suchergebnisse filtern